Active Filter(s):
Details:
CV6-168 is a first-in-class DNA uracilation agent that selectively targets the enzyme dUTPase.
Lead Product(s): CV6-168,Fluorouracil
Therapeutic Area: Oncology Product Name: CV6-168
Highest Development Status: IND Enabling Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 14, 2023